Baseline Investigations, median (range) |
Baseline Investigations,
median (range) |
Baseline Investigations, median (range) |
Baseline
Investigations, median (range) |
TLC, ×109/L |
6 (4-10) |
6 (4-10) |
6
(4-9) |
RBC, ×106/L |
5 (4-5) |
5 (4-5) |
4
(4-5) |
Hemoglobin, g/dL |
13 (11-17) |
14 (11-17) |
13 (12-15) |
Segmented Neutrophils, % |
72 (57-88) |
68 (57-88) |
75
(66-84) |
Lymphocytes, % |
15 (2-28) |
18 (2-28) |
11 (3-21) |
Platelets, ×109/L |
216 (85-487) |
208 (121-415) |
241
(85-487) |
ALT (U/L) |
24 (9-117) |
19 (9-46) |
40.5 (20-117) |
AST (U/L) |
50 (16-147) |
30 (16-86) |
61.5 (30-147) |
Total bilirubin (mg/dL) |
0.5 (0.2-1.6) |
0.5 (0.3-1.6) |
0.5
(0.2-1.1) |
GFR (CKD- EPI), mL/min/1.73 m2
|
62 (28-117) |
54
(28-103) |
93 (32-117) |
Urea (mg/dL) |
39 (12-129) |
35 (20-129) |
41.5 (12-82) |
Serum Creatinine (mg/dL) |
1 (0.6-2.2) |
1.1 (0.6-2.2) |
0.8
(0.7-1.9) |
LDH, U/L |
343 (169-931) |
299 (169-675) |
357 (265-931) |
C-reactive protein, mg/dL |
8 (1-17) |
6 (1-17) |
12
(3-17) |
Procalcitonin (ng/mL) |
0.12 (0.02-0.64) |
0.12 (0.02-0.64) |
0.12
(0.07-0.38) |
K+ (mmol/L) |
3.9 (3.1-5.1) |
3.8 (3.1-5.1) |
4
(3.4-4.9) |
Na+ (mmol/L) |
133 (128-143) |
133 (128-143) |
132.5
(130-137) |
Cl- (mmol/L) |
96.5 (91-102) |
96.5 (91-101) |
97
(91-102) |
Ca2+ (mmol/L) |
2.2 (1.6-2.5) |
2.3 (1.6-2.5) |
2.1
(2.1-2.3) |
Baseline Chest radiograph, No. (%) |
Baseline Chest radiograph, No.
(%) |
Baseline Chest radiograph, No. (%) |
Baseline Chest radiograph,
No. (%) |
Abnormal Chest Radiograph |
15 (79) |
8 (73) |
7 (88) |
Bilateral Lung Infiltrates |
12 (63) |
5 (45) |
7 (88) |
Unilateral Lung Infiltrates |
2 (11) |
2 (18) |
0 (0) |
Baseline Auscultation Findings, No. (%) |
|
|
|
Abnormal Auscultation |
14 (74) |
9 (82) |
5 (63) |
Bilateral Rales/Crepitation |
12 (63) |
7 (64) |
5 (63) |
Bilateral Wheezes |
2 (11) |
2 (18) |
0 (0) |